Publications by authors named "Max Novak"

Claim this Profile
B
Butyrylcholinesterase and 24 h-urinary copper excretion as compliance assessment in long-term treated Wilson's disease.
Harald Hefter, Max Novak, Dietmar Rosenthal, Sven G Meuth, Tom Luedde

Front Neurol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in the Time Course of Recovery from Brain and Liver Dysfunction in Conventional Long-Term Treatment of Wilson Disease.
Harald Hefter, Theodor S Kruschel, Max Novak, Dietmar Rosenthal, Tom Luedde

J Clin Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pseudocholinesterase as a Biomarker for Untreated Wilson's Disease.
Harald Hefter, Max Arslan, Theodor S Kruschel, Max Novak, Dietmar Rosenthal

Biomolecules· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholinesterase Deficiency Syndrome-A Pitfall in the Use of Butyrylcholinesterase as a Biomarker for Wilson's Disease.
Max Arslan, Max Novak, Dietmar Rosenthal, Christian J Hartmann, Philipp Albrecht

Biomolecules· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different Response Behavior to Therapeutic Approaches in Homozygotic Wilson's Disease Twins with Clinical Phenotypic Variability: Case Report and Literature Review.
Sara Samadzadeh, Theodor Kruschel, Max Novak, Michael Kallenbach, Harald Hefter

Genes (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis